超薄乳避孕套和标准乳避孕套的性能比较:一个随机的多中心试验
Frederic Esclassan1, Nina Tank2, Alice Switonski1
1Department of Medical Science, Reckitt Benckiser Plc, Slough, UK.
Contraception
|May 25, 2025
概括
超薄42微米天然乳避孕套的性能与较厚的避孕套相提并论. 这项研究表明,避孕套的薄度不会损害可靠性或增加失败率.
科学领域:
- 生殖健康 生殖健康
- 材料科学 材料科学 材料科学
- 临床试验 临床试验
背景情况:
- 避孕套的可靠性对于预防意外怀孕和性传播感染至关重要.
- 与标准厚度选项相比,人们对超薄避孕套的性能存在担忧.
- 自然乳 (NRL) 避孕套被广泛使用,需要对不同厚度的性能进行评估.
研究的目的:
- 为了评估超薄42微米天然乳膠避孕套的临床性能和安全性.
- 为了比较42微米的避孕套与两种更厚的商用避孕套 (55微米和70微米).
- 为了确定降低避孕套厚度是否会影响失效率,滑落或断裂.
主要方法:
- 在泰国进行的一项盲目,三向交叉,多中心的研究.
- 225对夫妇被随机分配到使用三个不同厚度的避孕套 (42微米,55微米,70微米) 在三个访问.
- 参与者使用了至少五种各厚度的避孕套,并报告了临床失败 (破裂,滑落) 和不良事件.
主要成果:
- 42微米的临床失败率为1.37%,55微米的2.12%,70微米的避孕套为1.68%.
- 42微米的避孕套被发现与55微米和70微米的参考避孕套无差.
- 不同的避孕套厚度之间没有观察到安全性概况的显著差异.
结论:
- 超薄的42微米天然乳避孕套符合国际标准化组织的标准.
- 避孕套的薄度,特别是<50微米,不会对失效率,滑落或破裂的性能产生不利影响.
- 这些发现支持超薄避孕套的可靠性,可能减轻用户对安全性受损的担忧.
更多相关视频
08:02Thin Film Composite Silicon Elastomers for Cell Culture and Skin Applications: Manufacturing and Characterization
Published on: July 3, 2018
10.7K
08:44An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
Published on: August 21, 2020
7.1K
相关概念视频
Birth Control Methods
5.6K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.6K
Intrauterine Drug Delivery Systems
170
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
170
